Hanil Pharm. Co. faces on critical edge of bankruptcy

The management control of Hanil Pharmaceutical company was transferred to Shin Dong-A group as a subsidiary in the general shareholder's meeting last year, but as of Apr. 2 this year the company was unable to pay the draft of 2,100 million Won arrived at the Shinhan Bank, bringing out the most difficult crisis.

The default took place amid a friction with the Chohung Bank, their major referri...